Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Digestive Neuroendocrine Tumors × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 395 Multiple Endocrine Neoplasia Type 1 156 Carcinoma, Neuroendocrine 121 Thyroid Cancer, Papillary 117 Pituitary Neoplasms 112 Thyroid Neoplasms 100 Pheochromocytoma 91 Neoplasms 79 Carcinoid Tumor 76 Thyroid Carcinoma, Anaplastic 73 Adrenocortical Carcinoma 73 Paraganglioma 65 Neoplasm Metastasis 57 Adenocarcinoma, Follicular 52 Carcinoma, Non-Small-Cell Lung 51 Carcinoma, Medullary 50 Insulinoma 49 Pancreatic Neoplasms 47 Adenoma, Islet Cell 47 Colorectal Neoplasms 44 Breast Neoplasms 44 Small Cell Lung Carcinoma 42 Sarcoma 42 Gastro-enteropancreatic neuroendocrine tumor 42 Carcinoma, Renal Cell 41 Somatostatinoma 38 Melanoma 37 Head and Neck Neoplasms 37 Lung Neoplasms 36 Adrenal Gland Neoplasms 34

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02465112 2019-02-28

TERAVECT

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 3 Terminated

Digestive Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡